GLAND Hits 52-Week High, Up 6.97%: Inside the Momentum Story Moving Gland Pharma Shares

Gland Pharma share price today, and the reason behind it

Shares of Gland Pharma last changed hands at ₹3,351.10 on the NSE board at 10:35 am IST on 9 November 2026 — +218.30 or +6.97% from the previous close of ₹3,132.80. Behind the number, the quote is at or above the reported twelve-month high; this comparison is not a forecast.

Key takeaways

• Where it trades: Gland Pharma is at ₹3,351.10, +218.30 (+6.97%) versus the previous close of ₹3,132.80.
• Why it is moving: a momentum story — one business desk filed on the company in the last few hours.
• Today's band: ₹3,140.80 to ₹3,362.00, against an open of ₹3,147.00 — the stock is defending its opening print.
• Twelve-month context: -4.44% below the ₹3,209 high and 112.96% above the ₹1,574 low, so the stock sits in the upper part of its own range.
• Participation: turnover is running at 4.1x the twenty-day average, so institutions are transacting rather than retail nibbling.
• What to watch: the stated measurement period and separately verified earnings comparisons.

The momentum angle

The reason Gland Pharma is on the desks today is a momentum story — reported by one desk so far, with the headlines linked below. Price performance alone does not establish earnings growth or a valuation re-rating.

Today's quote in numbers

Price-performance context

Price performance is not an explanation of its cause. Assess earnings and valuation separately before describing a move as a fundamental re-rating; historical gains do not establish future returns.

This is general context, not a finding about Gland Pharma. Company-specific conclusions require the cited disclosure.

Coverage across the desks

Headlines are listed for context and link straight to the publisher. The prices, ranges and tables on this page are read independently from exchange data at the timestamp shown.

• Gland Pharma shares hit 52-week high; jump 7% despite market sell-off | Will rally continue after 93% YTD rise? — Livemint

What the tape is saying

Gland Pharma's reported session range is ₹3,140.80 to ₹3,362.00, a spread of ₹221.20 (6.60% of the quoted price).

The quote of ₹3,351.10 is ₹204.10 above the open of ₹3,147.00. This comparison does not identify buyers, sellers or the cause of the move.

Performance across horizons

What the returns table is saying

Over the last week Gland Pharma has gained +9.28% and over the month +8.83%. These are separate measurement windows; neither confirms a reversal or continuation.

The reported twelve-month return is +78.15%. Price returns alone cannot establish earnings growth, valuation changes or the cause of the move.

Reading the price against its own ranges

Over the last twelve months the reported range is ₹1,574 to ₹3,209. The quote is 109% of the way through that band, -4.44% below the high and 112.96% above the low. These are historical comparisons, not support levels or return forecasts.

Traded quantity of 14,42,336 shares is 4.11x the reported 20-day average of 3,51,056. An intraday reading may cover less time than a full-day average. Volume does not identify institutional activity or predict persistence of the move.

Where this goes from here

For this momentum story specifically, watch the stated measurement period and separately verified earnings comparisons. On the chart, the ₹3,362.00 high and ₹3,140.80 low of this session are the reference levels — a higher low in the next session turns a headline reaction into a trend, a break of that low usually voids it. Participation is the third check: the move needs turnover at or above the stock's own 20-day average of 3,51,056 shares to be read as positioning rather than a squeeze.

Trader's view versus investor's view

For a trader, the setup is a range breakout: the reference is today's ₹3,362.00 high, and a close above it with volume keeps the trend intact. The invalidation is equally clean — a slip back under ₹3,140.80 puts the stock back inside the range it just left, and breakouts that fail tend to retrace to the middle of that range.

For a long-term shareholder, one session tells you very little. The stock is -4.44% off its twelve-month high, so the more useful exercise is comparing that drawdown with the change in earnings over the same period: price falling faster than profits is an opportunity, the reverse is a warning.

On risk: this report is a reading of live exchange data at a point in time, and intraday levels change. Position sizing — not conviction about the story — is what determines the outcome of a trade built on a headline, and averaging into a falling price without a change in the underlying facts is how a trade becomes an unintended long-term holding.

Our read

Gland Pharma is being bought on a momentum story, and at ₹3,351.10 the move is backed by turnover well above its own average, which is the version of a rally that tends to hold. The day's ₹3,140.80–₹3,362.00 band is the frame for the next session, and the stated measurement period and separately verified earnings comparisons is what resolves the story either way.

Where to track GLAND next

Live price, charts and technicals stay on the Gland Pharma stock page, and every filed quarter is tabulated on its quarterly results page. Both pages refresh from the exchange feed through the session, so they carry a later reading than this report once the market has moved on.

Frequently asked questions

What is the Gland Pharma share price today?

Gland Pharma (GLAND) last traded at ₹3,351.10, +218.30 (+6.97%) against the previous close of ₹3,132.80, read from the NSE board at 10:35 am IST on 9 November 2026.

Why is Gland Pharma in the news today?

1 business publisher ran headlines on the company in the last session — a momentum story. Their reports are linked above; the levels and tables here are read independently from exchange data.

What is the 52-week high and low of GLAND?

Over the last twelve months GLAND has traded between a low of ₹1,574 and a high of ₹3,209, computed from the adjusted daily series.

Is GLAND up or down today?

GLAND gained +6.97% in this session, trading between ₹3,140.80 and ₹3,362.00 against an open of ₹3,147.00.

Reporting method

This automated report uses the sources and reporting periods cited above. Publication time may differ from the underlying quote or filing time. Provider data can be delayed or revised; missing values are unavailable, not zero. Calculated comparisons do not establish the cause of a market move.

Related live pages

• Gland Pharma share price
• Gland Pharma quarterly results
• Stocks in news
• Top gainers
• Market dashboard

Sources

• NSE live board data via our exchange data feed
• Headline attribution links above point to the original publishers
• TrendRipperX Gland Pharma stock page

“This report is generated automatically from live exchange and official association data at the time stamped above. Prices move continuously — verify on the source before acting. Nothing here is investment advice.”